We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
PHGDH
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

ANTIBODY INFORMATION VALIDATION SUMMARY IMMUNOCYTOCHEMISTRY IMMUNOHISTOCHEMISTRY WESTERN BLOT PROTEIN ARRAY ANTIGEN INFORMATION RELEVANT PUBLICATIONS

ANTIBODY INFORMATION

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Provider

Atlas Antibodies
Sigma-Aldrich
  Atlas Antibodies
Sigma-Aldrich
  Abnova
  Atlas Antibodies
Sigma-Aldrich
 

Product name

HPA021241   HPA024031   H00026227-M01   AMAb90786  

Host species

Rabbit   Rabbit   Mouse   Mouse  

Clonality

pAb   pAb   mAb   mAb  

Purity

Affinity purified using the PrEST-antigen as affinity ligand   Affinity purified using the PrEST-antigen as affinity ligand   Protein A/G   Protein A/G  

Other gene match

       

Released in version

5   5   2   13  

References

8        

Proper citation

Atlas Antibodies Cat#HPA021241, RRID:AB_1855299   Atlas Antibodies Cat#HPA024031, RRID:AB_1855300   Abnova Corporation Cat#H00026227-M01, RRID:AB_425928   Atlas Antibodies Cat#AMAb90786, RRID:AB_2665666  

VALIDATION SUMMARY

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 
Immunocytochemistry

Approved   Approved   Approved    
Immunohistochemistry


Validated

Validated
 

Validated
  Supported   Supported  
Western blot

Supported   Supported   Supported   Supported  
Protein array

Approved   Supported      

IMMUNOCYTOCHEMISTRY

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Standard validation

Approved   Approved   Approved    

       

Figure description

Immunofluorescent staining of human cell line U-2 OS shows localization to plasma membrane & cytosol.   Immunofluorescent staining of human cell line MCF7 shows localization to nucleoplasm, plasma membrane & cytosol.   Immunofluorescent staining of human cell line U-2 OS shows localization to cytosol.    

Antibody dilution

1:22   1:39   1:188    

Literature conformity

The subcellular location is partly supported by literature or no literature is available.   The subcellular location is partly supported by literature or no literature is available.   The subcellular location is partly supported by literature or no literature is available.    

IMMUNOHISTOCHEMISTRY

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Formal validation: Orthogonal

Validated

Pearson correlation >0.6 for protein and RNA expression in cell lines.
       

       

Figure description

Distribution of protein expression (antibody staining) and RNA expression (TPM) across 44 cell lines.        
 

Formal validation: Independent

Validated

Pearson correlation >0.6 for protein expression in cell lines using independent antibodies.
 
Validated

Pearson correlation >0.6 for protein expression in cell lines using independent antibodies.
     

 
     

Figure description

Distribution of protein expression (antibody staining).
Pearson correlation with HPA024031 across 45 cell lines.
  Distribution of protein expression (antibody staining).
Pearson correlation with HPA021241 across 45 cell lines.
     
 

Standard validation

Supported   Supported   Supported   Supported  

       

Figure description

Immunohistochemical staining of human cervix, uterine shows cytoplasmic and nuclear positivity in squamous epithelia.   Immunohistochemical staining of human cervix, uterine shows nuclear and cytoplasmic positivity in squamous cells.   Immunohistochemical staining of human stomach shows strong cytoplasmic positivity in glandular cells.   Immunohistochemical staining of human skin shows strong cytoplasmic and nuclear positivity in epidermal cells.  

Expression

RNA: detected in 36 tissues
Protein: detected in 68 cell types
  RNA: detected in 36 tissues
Protein: detected in 70 cell types
  RNA: detected in 36 tissues
Protein: detected in 35 cell types
  RNA: detected in 36 tissues
Protein: detected in 74 cell types
 

Retrieval

HIER pH6   HIER pH6   HIER pH6   HIER pH6  

Antibody dilution

1:150   1:675   1:750   1:1300  

Literature conformity

No avaliable gene/protein characterization data.   No avaliable gene/protein characterization data.   No avaliable gene/protein characterization data.   No avaliable gene/protein characterization data.  

RNA consistency

Mainly not consistent with RNA expression data.   Mainly not consistent with RNA expression data.   Mainly consistent with RNA expression data.   Mainly consistent with RNA expression data.  

WESTERN BLOT

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Standard validation

Supported

Analysis performed using a standard panel of samples.
Single band corresponding to the predicted size in kDa (+/-20%).
  Supported

Analysis performed using a standard panel of samples.
Band of predicted size in kDa (+/-20%) with additional bands present.
  Supported

Analysis performed using a standard panel of samples.
Band of predicted size in kDa (+/-20%) with additional bands present.
  Supported

Analysis performed using a standard panel of samples.
Single band corresponding to the predicted size in kDa (+/-20%).
 

       

Figure description

Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
  Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
  Lane 1: Marker [kDa] 219, 112, 85, 49, 32, 25, 17.5
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: A-431
Lane 5: Liver
Lane 6: Tonsil
  Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
 

Target mass (kDa)

56.6, 53.1   56.6   56.6, 53.1   56.6, 53.1  

Antibody dilution

1:250   1:250   1:500   1:1000  

PROTEIN ARRAY

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Standard validation

Approved

Pass with quality comment low specificity (binding to 1-2 PrESTs >15% and <40%).
  Supported

Pass with single peak corresponding to interaction only with its own antigen.
     

       

Figure description

Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.   Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.      

Antibody dilution

1:3000   1:3000      

ANTIGEN INFORMATION

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

Antigen

Recombinant protein fragment   Recombinant protein fragment   Recombinant protein   Recombinant protein  

Length (aa)

114   91      

Antigen sequence

LEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDE
GALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQ
SRCGEEIAVQFVDM
 
KVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSAT
KVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNT
     

Matching transcripts

PHGDH-001 - ENSP00000358417 [100%]
PHGDH-002 - ENSP00000358415 [100%]
  PHGDH-001 - ENSP00000358417 [100%]
     

Other gene match

       
ANTIGEN VIEW
PHGDH-001
PHGDH-002

RELEVANT PUBLICATIONS

 
 

Antibody HPA021241

 

Antibody HPA024031

 

Antibody CAB003681

 

Antibody CAB068216

 

1.

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato R et al
Nature 2011;476(7360):346-50
       

2.

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks OD et al
Nature 2013;493(7433):542-6
       

3.

Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis
Nilsson LM et al
PLoS Genet 2012;8(3):e1002573
       

4.

An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation
Mattaini KR et al
Cancer Metab 2015;3:5
Application: ICC-IF, WB
       

5.

Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability
Markkanen E et al
Nucleic Acids Res 2015;43(7):3667-79
Application: WB
       

6.

A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Pacold ME et al
Nat Chem Biol 2016;12(6):452-8
Application: WB
       

7.

NRF2 regulates serine biosynthesis in non-small cell lung cancer
DeNicola GM et al
Nat Genet 2015;47(12):1475-81
Application: WB
       

8.

Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
Mullarky E et al
Proc Natl Acad Sci U S A 2016;113(7):1778-83
Application: WB
       
 

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.